PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 23 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Small molecular weight compounds and crude aqueous extracts from the subterranean system inhibit the phospholipase activity and myotoxic activity of Crotalus durissus terrificus venom [PMID: 1842000, PMID: 14644557]
Crude extract (50-200 mg/kg) inhibits bradykinin and cellulose sulphate-induced rat paw oedema and pleural exudate [PMID: 1719783]
Velutinol A practically abolished nociceptive effects caused by phorbol myristate acetate and partially inhibited capsaicin-induced responses [PMID: 16494941]; compound MV8612 inhibited thermal hyperalgesia caused by bradykinin and formalin-induced pain [PMID: 12531494]
Evidence summary
PubMed sources
- 1.PMID: 1842000 (1991) — Plants against snake-bites. · Memorias do Instituto Oswaldo Cruz
- 2.PMID: 3742164 (1986) — Effect of a crude extract of Mandevilla velutina on contractions induced by bradykinin and [des-Arg9]-bradykinin in isolated vessels of the rabbit. · British journal of pharmacology
- 3.PMID: 14644557 (2003) — Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract. · Biochimie
- 4.PMID: 1719783 (1991) — Inhibition of rat paw oedema and pleurisy by the extract from Mandevilla velutina. · Agents and actions
- 5.PMID: 39461387 (2025) — Antioxidant and anti-glycation activities of Mandevilla velutina extract and effect on parasitemia levels in Trypanosoma cruzi experimental infection: In vivo, in vitro and in silico approaches.